Ischemic preconditioning modifies mortality and inflammatory response

PURPOSE: To evaluate the effect of ischemic preconditioning on mortality, inflammatory mediators and oxidative stress after intestinal ischemia and reperfusion. METHODS: Male Wistar rats were allocated according to the period of ischemia with or without ischemic preconditioning which consist on clamping the superior mesenteric artery for 10 minutes followed by reperfusion for 10 minutes before the sustained ischemia period. Mortality was assessed in Phase 1 study, and the CINC-1, CINC-2 and MDA levels in the lungs were analyzed in Phase 2. RESULTS: Mortality was lower in the ischemic preconditioning group subjected to 90 minutes of ischemia compared to the group without ischemic preconditioning (I-90: 50% and IPC-90: 15%, p=0.018), and it was lower in the ischemic preconditioning group as a whole compared to the groups without ischemic preconditioning (IPC-14% and I=30%, p=0.006). Lower levels of MDA, CINC-1, and CINC-2 were observed in the animals that were subjected to ischemic preconditioning compared to the animals that were not (MDA: I-45=1.23 nmol/mg protein, and IPC-45=0.62 nmol/mg protein, p=0.0333; CINC-1: I-45=0.82 ng/mL and IPC-45=0.67 ng/mL, p=0.041; CINC-2: I-45=0.52 ng/mL and IPC-45=0.35 ng/mL, p=0.032). CONCLUSION: Ischemic preconditioning reduces mortality, inflammatory process and oxidative stress in rats subjected to intestinal ischemia and reperfusion.

Palavras-chave

Ischemic Preconditioning, Reperfusion, Mortality, Oxidative Stress, Rats

URI

https://observatorio.fm.usp.br/handle/OPI/13622

Referências

Wang SF, 2003, WORLD J GASTROENTERO, V9, P1866
Grotto D, 2007, J PHARMACEUT BIOMED, V43, P619, DOI 10.1016/j.jpba.2006.07.030
Tsuboi H, 2007, AM J PHYSIOL-GASTR L, V292, pG678, DOI 10.1152/ajpgi.00361.2006
Sola A, 2004, APOPTOSIS, V9, P353, DOI 10.1023/B:APPT.0000025812.45382.4d
McCallion K, 2000, SHOCK, V14, P429, DOI 10.1097/00024382-200014040-00002
KOIKE K, 1992, J SURG RES, V52, P656
Coelho AMM, 2011, J GASTROINTEST SURG, V15, P1679, DOI 10.1007/s11605-011-1648-x
MURRY CE, 1986, CIRCULATION, V74, P1124
Figueira ERR, 2010, SURGERY, V147, P415, DOI 10.1016/j.surg.2009.10.018
Tamion F, 2007, AM J PHYSIOL-GASTR L, V293, pG1308, DOI 10.1152/ajpgi.00154.2007
Huang YC, 2009, TRANSPL IMMUNOL, V20, P127, DOI 10.1016/j.trim.2008.08.002
Sola A, 2000, TRANSPLANTATION, V69, P767
Hotter G, 1996, BIOCHEM BIOPH RES CO, V222, P27, DOI 10.1006/bbrc.1996.0692
Kozar RA, 2004, J SURG RES, V116, P145, DOI 10.1016/S0022-4804(03)00301-9
Jacome DT, 2009, TRANSPL P, V41, P827, DOI 10.1016/j.transproceed.2009.01.071
Ito K, 2003, SHOCK, V19, P462, DOI 10.1097/01.shk.0000055240.25446.16
Aksoyek S, 2002, SHOCK, V18, P476
Wu B, 2004, AM J PHYSIOL-GASTR L, V286, pG580, DOI 10.1152/ajpgi.00335.2003
Shibata F, 1996, CYTOKINE, V8, P222, DOI 10.1006/cyto.1996.0031
Avgerinos ED, 2010, J SURG RES, V160, P294, DOI 10.1016/j.jss.2008.12.017
Rupani B, 2007, SURGERY, V141, P481, DOI 10.1016/j.surg.2006.10.008
Moraes LB, 2008, J TRAUMA, V64, P1196, DOI 10.1097/TA.0b013e31816c5ca6
Mallick IH, 2004, DIGEST DIS SCI, V49, P1359, DOI 10.1023/B:DDAS.0000042232.98927.91
Sola A, 1999, TRANSPLANTATION, V67, P1446, DOI 10.1097/00007890-199906150-00010
Mallick IH, 2010, AM J SURG, V199, P223, DOI 10.1016/j.amjsurg.2009.01.011
Korth U, 2003, RESUSCITATION, V58, P209, DOI 10.1016/S0300-9572(03)00119-9
Tamion F, 2002, AM J PHYSIOL-GASTR L, V283, pG408, DOI 10.1152/ajpgi.00348.2001
Castro e Silva Jr O, 2002, ACTA CIR BRAS, V17, P96, DOI 10.1590/S0102-86502002000900020
Kubes P, 2002, AM J PHYSIOL-GASTR L, V283, P139, DOI [10.1152/ajpgi00058.2002, DOI 10.1152/AJPGI00058.2002]
Neves JS, 2011, ACTA CIR BRAS, V26, P496
Parks DA, 1986, AM J PHYSIOL, V250, P749
Tomanari G. Y., 2003, REV BRAS TER COMPORT, V5, P57
Zitta K, 2012, MOL MED, V1, P29

Coleções

Artigos e Materiais de Revistas Científicas - FM/MCG
Artigos e Materiais de Revistas Científicas - HC/ICHC
Artigos e Materiais de Revistas Científicas - LIM/62

Página do item completo